How have CERO shares performed in 2024?

CERo Therapeutics' stock was trading at $4.78 at the start of the year. Since then, CERO stock has decreased by 71.3% and is now trading at $1.37. View the best growth stocks for 2024 here .

How do I buy shares of CERo Therapeutics?

Shares of CERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CERO

CERo Therapeutics (CERO) Stock Price, News & Analysis

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)

Free CERO Stock Alerts

$1.37

-0.04 (-2.84%)

(As of 04/26/2024 ET)

Compare

Today's Range: $1.37
▼
$1.47
50-Day Range: $1.35
▼
$4.78
52-Week Range: $1.33
▼
$12.80

Volume: 94,318 shs
Average Volume: 485,512 shs
Market Capitalization: $20.17 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Headlines SEC Filings Social Media

Get CERo Therapeutics alerts:

Ad Prosper Trading Academy

These AI trades triggered this morning (545% return)

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy

About CERo Therapeutics Stock (NASDAQ:CERO)

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

CERO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CERO Stock News Headlines

April 26, 2024 | americanbankingnews.com

CERo Therapeutics (NASDAQ:CERO) Shares Down 3.2%

March 30, 2024 | msn.com

Compare with Bloomberg Emerging Markets Large & Mid Cap Total Return Index NOK (EMTK)

April 28, 2024 | Banyan Hill Publishing (Ad)

Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

March 21, 2024 | wsj.com

CERo Therapeutics Holdings Inc.

March 17, 2024 | morningstar.com

CERo Therapeutics Holdings Inc CERO

March 11, 2024 | finance.yahoo.com

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

See More Headlines

Receive CERO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CERo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/28/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Holding & other investment offices
Sub-Industry: N/A
Current Symbol: NASDAQ:CERO
Previous Symbol: NASDAQ:CERO
CUSIP: N/A
CIK: 1870404
Web: www.cero.bio
Phone: 215-731-9450
Fax: N/A
Employees: 8
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 14,720,000
Free Float: 2,238,000
Market Cap: $20.17 million
Optionable: N/A
Beta: -0.38

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Dr. Daniel Mark Corey M.D. (Age 45)
Founder, CTO & Director
Comp: $372.69k
Mr. Brian G. Atwood (Age 71)
President, CEO & Chairman
Mr. Charles Ross Carter (Age 56)
CFO, Treasurer & Corporate Secretary
Dr. Robert Sikorski M.D. (Age 61)
Ph.D., Consultant

Key Competitors

View All Competitors

CERO Stock Analysis - Frequently Asked Questions

How have CERO shares performed in 2024?: CERo Therapeutics' stock was trading at $4.78 at the start of the year. Since then, CERO stock has decreased by 71.3% and is now trading at $1.37.
View the best growth stocks for 2024 here.
How do I buy shares of CERo Therapeutics?: Shares of CERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CERO) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial